Condition: COVID-19 Pneumonia · Sepsis · SARS-CoV-2 Acute Respiratory Disease · Sponsor: Osijek University Hospital
The research will be retrospective, and will include all patients who were admitted during 2020 and 2021 in the COVID-19 ICU of University Hospital Center Osijek due to pneumonia caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The association of chest x-ray infiltrate evolution with changes in laboratory inflammatory parameters and respiratory function parameters will be examined.
This description comes directly from the study's public registry record.
Nenad Nešković, PhD · +395996787250 · nneskov@gmail.com
Ivana Haršanji Drenjančević, PhD · +385915108941 · ihdrenjan@gmail.com
Always discuss trial participation with your own doctor first.
| University hospital Osijek | Osijek, Croatia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05181696